RSV-F eiwit (C-His, RSV)

RSV-F

C-His

< 1.0 EU per μg of the protein as determined by the LAL method

≥ 90 % as determined by SDS-PAGE. ≥ 90 % as determined by SEC-MALS.

1.Immobilized Human respiratory syncytial virus (RSV) (A2) Prefusion glycoprotein F/RSV-preF Protein (Cat: 11049-VNAS) at 1 μg/mL (100μL/well) can bind Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (Site Ø) (Nirsevimab), the EC50 is 30-90 ng/mL, Recombinant RSV (A2) Post-fusion glycoprotein F/ RSV post-F Protein (His Tag) (Cat: 11049-V08H5) is verified not recoginized by Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (Site Ø) (Nirsevimab) in low concentration (QC tested) . 2.Immobilized Human respiratory syncytial virus (RSV) (A2) Prefusion glycoprotein F/RSV-preF Protein (Cat: 11049-VNAS) and Recombinant RSV (A2) Post-fusion glycoprotein F/ RSV post-F Protein (His Tag) (Cat: 11049-V08H5) at 1 μg/mL (100μL/well) can bind Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (site II) (Palivizumab), the EC50 is 2-6 ng/mL (Routinely tested) . 3.Immobilized Human respiratory syncytial virus (RSV) (A2) Prefusion glycoprotein F/RSV-preF Protein (Cat: 11049-VNAS) at 1 μg/mL (100μL/well) can bind Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (siteV) (Suptavumab), the EC50 is 2-6 ng/mL, Recombinant RSV (A2) Post-fusion glycoprotein F/ RSV post-F Protein (His Tag) (Cat: 11049-V08H5) is verified not recoginized by Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (siteV) (Suptavumab) in low concentration (Routinely tested) .

It migrates as an approximately 43.7 kDa band in SDS-PAGE under reducing conditions. The molecular weight of this protein is around 173.4 kDa verified by SEC-MALS.

RSV